Table 1. Characteristics of included patients.

Demography	n = 31
Age (years)	56 [32–70]
Gender ratio (M/F)	18/13
Time since transplantation (months)	126 [18–326]
Body-mass index at inclusion (kg/m2)	23.8 [18.2–36.8]
Diabetes, n (%)	3 (10)
Biology
Creatininemia (μmol/L)	145 [87–239]
eGFR (mL/min/1.73 m2)	41 [26–59]
Serum potassium at inclusion (mmol/L)	4.2 [3.4–4.9]
Serum bicarbonate at inclusion (mmol/L)	24 [12–30]
Natriuresis at inclusion (mmol/d)	136 [29–360]
Kaliuresis at inclusion (mmol/d)	60 [0–176]
Proteinuria at inclusion (mg/d)	123 [0–648]
Drug therapies
Cyclosporine posology at inclusion (mg/kg/d)	2.1 [1.4–4.0]
Cyclosporinemia at inclusion (ng/mL)	94 [38–152]
MMF/azathioprine, n (%) / n (%)	24 (77) / 4 (1)
ACE-i/ARB, n (%) / n (%)	13 (42) / 6 (2)
Diuretics, n (%)	12 (39)
β-blockers, n (%)	14 (45)
Oral bicarbonate, n (%)	7 (23)
Steroids, n (%)	5 (16)

M: male; F: female; eGFR: estimated glomerular-filtration rate; MMF: mycophenolate mofetil. Data are expressed by their median [range].